Ann: Quarterly Update and Appendix 4C, page-3

UTo be honest, I am very disappointed with the Q3 performance. Cash flow is concerning me for this quarter if something is not going as planned.

If some positive could be spined off, that the products of Abiomed go back to normal post Q3 is the only one impresses me.

As COVID-19 sensor, I don’t know how to understand “Nanodx has continued to have challenges to releasing their SARS-Cov-2 detection system”.

what has not happened is never guaranteed. Therefore I would not take “going to happen” as a given.